...
This example shows findings from an assessment of the number of mutations within a tumor genome with the purpose of determining likely response to immunotherapy. (Need to add description here)
...
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| STUDYID | DOMAIN | USUBJID | SPDEVID | NHOID | GFSEQ | GFGRPID | GFREFID | GFSPID | GFLNKID | GFLNKGRP | GFTESTCD | GFTEST | GFTSTDTL | GFCAT | GFSCAT | GFORRES | GFORRESU | GFORREF | GFSTRESC | GFSTRESN | GFSTRESU | GFSTREFC | GFSTREFN | GFRESCAT | GFINHERT | GFGENREF | GFCHROM | GFSYM | GFSYMTYP | GFGENLOC | GFGENSR | GFSEQID | GFPVRID | GFCOPYID | GFSTAT | GFREASND | GFXFN | GFNAM | GFSPEC | GFMETHOD | GFRUNID | GFANMETH | GFBLFL | GFDRVFL | GFLLOQ | GFREPNUM | VISITNUM | VISIT | VISITDY | GFDTC | GFDY | GFTPT | GFTPTNUM | GFELTM | GFTPTREF | GFRFTDTC | | ABC-123 | GF | ABC123-45-001 | ACME 500 GENE PANEL |
| 1 |
| 96757855 |
|
|
| TMB | Tumor Mutation Burden | NORMALIZED NUMBER OF SEQUENCE VARIANTS |
|
| 8.83 | /MBP |
| 8.83 | 8.83 | /MBP |
|
|
|
| GRCh37.75 |
|
|
|
|
|
|
|
|
|
|
| ACME Genetics Inc. | ctDNA | NEXT GENERATION TARGETED SEQUENCING |
| Uniform TMB Calculation Method Merino et al 2020 FORMULA |
|
|
|
| 1 | SCREENING | <ADD HERE> | <ADD HERE> | <ADD HERE> |
|
|
|
|
| | ABC-123 | GF | ABC123-45-001 | ACME 500 GENE PANEL |
| 2 |
| 96757855 |
|
|
| TMB | Tumor Mutation Burden | VARIANT SEQUENCE BURDEN INTERPRETATION |
|
| intermediate |
|
| intermediate |
|
|
|
|
|
| GRCh37.75 |
|
|
|
|
|
|
|
|
|
|
| ACME Genetics Inc. | ctDNA | NEXT GENERATION TARGETED SEQUENCING |
|
|
|
|
|
| 1 | SCREENING | <ADD HERE> | <ADD HERE> | <ADD HERE> |
|
|
|
|
| | ABC-123 | GF | ABC123-45-001 |
|
| 3 |
| 78975864 |
|
|
| TMB | Tumor Mutation Burden | NUMBER OF SEQUENCE VARIANTS |
|
| 497 |
|
| 497 | 497 |
|
|
|
|
| GRCh37.75 |
|
|
|
|
|
|
|
|
|
|
| Genetics Lab Plus | DNA | WHOLE EXOME SEQUENCING |
|
|
|
|
|
| 1 | SCREENING | <ADD HERE> | <ADD HERE> | <ADD HERE> |
|
|
...